Popescu said that the setting up of the lowest European price for medicines in Romania, which is then impacted by the clawback tax, represents a mechanism which could not trigger economic health for the pharmaceutical operators, either international or local producers, distributors or pharmacies.
In his opinion, there will be an advantage for the “patient’s pocket”, but, from the point of view of the costs for National Health Insurance Fund, there will be no direct savings, but indirect ones, as the companies will pay a lower clawback tax.
Health Minister Nicolae Banicioiu stated Monday that Romania will have the lowest price for medicines in Europe as of July 1, after the procedure to cut medicine prices by 20% was completed.